FDA Inspection 1076080 — Akorn Operating Company LLC
The FDA completed an inspection of Akorn Operating Company LLC on Nov 16, 2018 in Cranbury, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 16, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cranbury, NJ (United States)
Additional Details
Bioanalytical BA/BE